NEWS & VIEWS

Global private equity and venture capital news and research

Archive for 2001

20 December 2001

Russian private equity: right time, right place?p

Just a couple of years ago, few investors would have touched Russia. Now, largely untainted by the new economy boom that has affected Western economies and with economic reforms starting to take effect, Russia is looking increasingly attractive. And, as one of the few financing options available to fledgling companies in this huge market, private equity looks set to reap the benefits, says Nikoil's Steve Geiger.

20 December 2001

Ten trends for what’s aheadp

If the technology sector is to attract investment again, it must shake off the negative connotations that are associated with it. Red Herring dares to make some forecasts for the next year by predicting some trends that will emerge in this sector.

20 December 2001

Adventures in corporate venturingp

Although many of the earliest dot.com contenders have stumbled and even collapsed on the road to riches, well established companies, no matter what their industry, cannot afford to be complacent. Jill Albrinck, Jennifer Hornery, David Kletter and Gary Neilson of Booz-Allen Hamilton discuss the corporate venturing phenomenon and the issues that it raises for large corporations.

20 December 2001

And the new economy winner is … Europep

The European Union is emerging as a formidable competitor among world economies, thanks to an aptitude for cross-border management and an ease with cultural diversity. Business journalist Stuart Crainer discusses how Europe's economy is finally emerging from the shadow of the US.

20 December 2001

Boston Scientific and Vitalife join forces

Boston Scientific has announced that it will make an investment in Vitalife Life Sciences, a venture capital fund based in Tel Aviv, signalling an attempt to foster the development of medical technology in Israel.

20 December 2001

European allocation to private equity to rise, says survey

European institutional investors plan to increase their allocation to private equity over the next few years, according to the latest edition of the Goldman Sachs/Frank Russell report on alternative investment.

19 December 2001

Examining the latest developments and potential of the securitisation of private equity portfoliosp

There has been increasing interest in creating innovative ways of attracting investors unable to commit to private equity limited partnerships. Securitisation is one option. Urs Wietlisbach of Partners Group offers some information on this emerging market.

19 December 2001

Flight to biotech continues with record Swedish venture round

The bonanza in the biotech sector continued this week with the completion of Sweden's biggest ever biotech venture round. Gyros AB announced it had raised $30m during its second round financing, making it one of Europe's largest biotech fund raisings of the year.

19 December 2001

Cinven announces closing of third fund at more than E3.5bn

European buy-out specialist Cinven has announced a closing of its third fund at E3.5bn, comfortably outstripping its original target to become one of the largest ever raised in Europe. Further closings are expected early in the New Year.

19 December 2001

Institutional investor profile, Simon Thornton, Landmark Partners Europep

Landmark Partners is a US-based firm with $3.5bn under management, of which 75 per cent is dedicated to private equity. The remainder is invested in real estate. Established in 1984, the firm specialises in secondaries investments, but also commits capital to first-time funds. Landmark Partners Europe, which is headed by Simon Thornton, advises Landmark on European and Middle Eastern activities.

Page 1 of 8212345...102030...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014